STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 260.81 USD -0.86% Market Closed
Market Cap: $25.6B

Net Margin

12.1%
Current
Improving
by 4.4%
vs 3-y average of 7.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.1%
=
Net Income
$688.5m
/
Revenue
$5.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.1%
=
Net Income
$688.5m
/
Revenue
$5.7B

Peer Comparison

Country Company Market Cap Net
Margin
IE
STERIS plc
NYSE:STE
25.6B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.1B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Higher than 76% of companies in Ireland
Percentile
76th
Based on 314 companies
76th percentile
12.1%
Low
-6 913.1% — 0%
Typical Range
0% — 10.2%
High
10.2% — 197.7%
Distribution Statistics
Ireland
Min -6 913.1%
30th Percentile 0%
Median 3.1%
70th Percentile 10.2%
Max 197.7%

STERIS plc
Glance View

Emerging as a silent pioneer in the intricate world of sterilization and infection prevention, STERIS plc has carved out a significant niche in the healthcare industry. Originally founded in 1985, the company has grown through strategic acquisitions and organic expansion. It primarily focuses on protecting patients by ensuring high standards of cleanliness and safety in healthcare environments. STERIS offers a broad array of products and services, from sophisticated sterilization equipment for hospital operating rooms to surface disinfectants and washes that keep healthcare facilities safe and clean. Their diverse portfolio ensures that they can meet the evolving needs of the global healthcare sector, which increasingly demands stringent infection control protocols. What sets STERIS apart is its innovative approach to both service and product offerings, which blend together to create comprehensive infection prevention solutions. By marrying state-of-the-art technology with a service-oriented business model, the company supports hospitals, medical-device companies, and research labs by maintaining their operational readiness and compliance with health standards. Revenue is generated through a mix of product sales as well as renewable service contracts, which guarantee recurring income. These long-term service agreements, alongside the consistent demand for advanced sterilization solutions, have enabled STERIS to sustain and even enhance its financial health while supporting the mission of safer patient care globally.

STE Intrinsic Value
214.55 USD
Overvaluation 18%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
12.1%
=
Net Income
$688.5m
/
Revenue
$5.7B
What is STERIS plc's current Net Margin?

The current Net Margin for STERIS plc is 12.1%, which is above its 3-year median of 7.7%.

How has Net Margin changed over time?

Over the last 3 years, STERIS plc’s Net Margin has increased from -0.2% to 12.1%. During this period, it reached a low of -0.6% on Dec 31, 2022 and a high of 12.1% on Sep 30, 2025.

Back to Top